BACKGROUND: Gβγ interaction with GlyR is an important determinant in ethanol potentiation of this channel. RESULTS: A small peptide, RQH(C7), can inhibit ethanol potentiation of GlyR currents. CONCLUSION: Results with RQH(C7) indicate that ethanol mediated potentiation of GlyR is in part by Gβγ activation. SIGNIFICANCE: Molecular interaction between Gβγ and GlyR could be used as a target for pharmacological modification of ethanol effects. Previous studies indicate that ethanol can modulate glycine receptors (GlyR), in part, through Gβγ interaction with basic residues in the intracellular loop. In this study, we show that a seven-amino acid peptide (RQH(C7)), which has the primary structure of a motif in the large intracellular loop of GlyR (GlyR-IL), was able to inhibit the ethanol-elicited potentiation of this channel from 47 ± 2 to 16 ± 4%, without interfering with the effect of Gβγ on GIRK (G protein activated inwardly rectifying potassium channel) activation. RQH(C7) displayed a concentration-dependent effect on ethanol action in evoked and synaptic currents. A fragment of GlyR-IL without the basic amino acids did not interact with Gβγ or inhibit ethanol potentiation of GlyR. In silico analysis using docking and molecular dynamics allowed to identify a region of ~350Å(2) involving aspartic acids 186, 228, and 246 in Gβγ where we propose that RQH(C7) binds and exerts its blocking action on the effect of ethanol in GlyR.
BACKGROUND: Gβγ interaction with GlyR is an important determinant in ethanol potentiation of this channel. RESULTS: A small peptide, RQH(C7), can inhibit ethanol potentiation of GlyR currents. CONCLUSION: Results with RQH(C7) indicate that ethanol mediated potentiation of GlyR is in part by Gβγ activation. SIGNIFICANCE: Molecular interaction between Gβγ and GlyR could be used as a target for pharmacological modification of ethanol effects. Previous studies indicate that ethanol can modulate glycine receptors (GlyR), in part, through Gβγ interaction with basic residues in the intracellular loop. In this study, we show that a seven-amino acid peptide (RQH(C7)), which has the primary structure of a motif in the large intracellular loop of GlyR (GlyR-IL), was able to inhibit the ethanol-elicited potentiation of this channel from 47 ± 2 to 16 ± 4%, without interfering with the effect of Gβγ on GIRK (G protein activated inwardly rectifying potassium channel) activation. RQH(C7) displayed a concentration-dependent effect on ethanol action in evoked and synaptic currents. A fragment of GlyR-IL without the basic amino acids did not interact with Gβγ or inhibit ethanol potentiation of GlyR. In silico analysis using docking and molecular dynamics allowed to identify a region of ~350Å(2) involving aspartic acids 186, 228, and 246 in Gβγ where we propose that RQH(C7) binds and exerts its blocking action on the effect of ethanol in GlyR.
Authors: Gonzalo E Yevenes; Robert W Peoples; Juan C Tapia; Jorge Parodi; Ximena Soto; Juan Olate; Luis G Aguayo Journal: Nat Neurosci Date: 2003-08 Impact factor: 24.884
Authors: Brigitte van Zundert; Francisco J Alvarez; Gonzalo E Yevenes; Juan G Cárcamo; Juan Carlos Vera; Luis G Aguayo Journal: J Neurophysiol Date: 2002-01 Impact factor: 2.714
Authors: Carlos F Burgos; Patricio A Castro; Trinidad Mariqueo; Marta Bunster; Leonardo Guzmán; Luis G Aguayo Journal: J Pharmacol Exp Ther Date: 2014-10-22 Impact factor: 4.030
Authors: Luis G Aguayo; Patricio Castro; Trinidad Mariqueo; Braulio Muñoz; Wei Xiong; Li Zhang; David M Lovinger; Gregg E Homanics Journal: Neuropsychopharmacology Date: 2014-05-07 Impact factor: 7.853
Authors: Trinidad A Mariqueo; Adolfo Agurto; Braulio Muñoz; Loreto San Martin; Cesar Coronado; Eduardo J Fernández-Pérez; Pablo Murath; Andrea Sánchez; Gregg E Homanics; Luis G Aguayo Journal: J Neurophysiol Date: 2014-02-26 Impact factor: 2.714
Authors: Lynda Sharrett-Field; Tracy R Butler; Anna R Reynolds; Jennifer N Berry; Mark A Prendergast Journal: Pflugers Arch Date: 2013-04-05 Impact factor: 3.657
Authors: Andrea Sánchez; Gonzalo E Yévenes; Loreto San Martin; Carlos F Burgos; Gustavo Moraga-Cid; Robert J Harvey; Luis G Aguayo Journal: J Pharmacol Exp Ther Date: 2015-04 Impact factor: 4.030